Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury

• 收藏
• 分享

专利权人:

CURONZ HOLDINGS COMPANY LIMITED

发明人:

SIEG FRANK

申请号：

NZ61706912

公开号：

NZ617069A

申请日:

2012.07.27

申请国别(地区):

NZ

年份:

2015

代理人:

摘要：

Disclosed is the use of an effective amount of a peptide comprising the sequence GRRAAPGRAGG or GRRAAPGRAGG-NH2 in the manufacture of a medicament for treating or preventing (i) optic nerve damage (ii) an ophthalmic reperfusion injury or (iii) ophthalmic ischemia in an eye of a subject in need thereof. Also disclosed is a method of treating or preventing optic nerve damage, an ophthalmic reperfusion injury or ophthalmic ischemia in a non-human subject comprising administering comprising administering an effective amount of a peptide comprising the sequence GRRAAPGRAGG or GRRAAPGRAGG-NH2 to an eye of a subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/